Go to main navigation Go to main content Go to footer

Dr. Monés takes part in the second refresher course on Retina Dystrophies

jordimones_red_editora_15_42_1.jpg

On the 8th and 9th of October, the second refresher course on Retina Dystrophies will take place at the Jiménez Díaz Foundation of Madrid. A meeting where scientists, clinical experts and patients can exchange knowledge in order to promote the development of clinical trials in diseases that still have no effective treatment.

It is organized by CIBERER, the CIBER-BBN, the Genetic Department –IIS- Jiménez Díaz Foundation, the Research Chair “Bidons Egara” and the Miguel Hernández University of Elche and has a clear theoretical-practical orientation. Furthermore, it aims to promote the development and the application of the most advanced scientific knowledge to clinical practice.

On the second day of the course Dr. Jordi Monés will give a talk entitled: Retina dystrophies: diagnosis, treatment and patient monitoring. In this session Dr. Monés will talk about the clinical diagnosis of the three main diseases that are included in most of the research projects of the Barcelona Macula Foundation: atrophic AMD, Retinitis Pigmentosa and Stargardt Disease. In this talk Dr. Monés will explain the use of different techniques (perimetry, Spectral domain optical coherence tomography (SD-OCT), autofluorescence, electroretinography and microperimetry) in the diagnosis and monitoring of the progression and follow-up of these three degenerative diseases.

Also participating on this day will be other experts in genetic, molecular, cellular, functional and clinical testing, such as Dr. Carmen Ayuso of IIS-FJD and CIBERER, Dr. J. M. Millán of University Hospital La Fe and CIBERER and Dr. Marcelino Avilés of the Research Chair Bidons Egara of the University of Murcia.

This course also seeks to promote the role of those involved in translational research and to update and disclose ethical and legal aspects of clinical trials and of their general design. So Tuesday was an open day for patients to inform them of Treatment for rare Diseases: retina dystrophies.

Research is the only solution for the future to fight against blindness

It is only with your help that we can fight against blindness

Collaborate